IFITM protein regulation and functions: Far beyond the fight against viruses
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00209805%3A_____%2F22%3A00079130" target="_blank" >RIV/00209805:_____/22:00079130 - isvavai.cz</a>
Alternative codes found
RIV/00216224:14310/22:00128462
Result on the web
<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716219/pdf/fimmu-13-1042368.pdf" target="_blank" >https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716219/pdf/fimmu-13-1042368.pdf</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.3389/fimmu.2022.1042368" target="_blank" >10.3389/fimmu.2022.1042368</a>
Alternative languages
Result language
angličtina
Original language name
IFITM protein regulation and functions: Far beyond the fight against viruses
Original language description
Interferons (IFNs) are important cytokines that regulate immune responses through the activation of hundreds of genes, including interferon-induced transmembrane proteins (IFITMs). This evolutionarily conserved protein family includes five functionally active homologs in humans. Despite the high sequence homology, IFITMs vary in expression, subcellular localization and function. The initially described adhesive and antiproliferative or pro-oncogenic functions of IFITM proteins were diluted by the discovery of their antiviral properties. The large set of viruses that is inhibited by these proteins is constantly expanding, as are the possible mechanisms of action. In addition to their beneficial antiviral effects, IFITM proteins are often upregulated in a broad spectrum of cancers. IFITM proteins have been linked to most hallmarks of cancer, including tumor cell proliferation, therapeutic resistance, angiogenesis, invasion, and metastasis. Recent studies have described the involvement of IFITM proteins in antitumor immunity. This review summarizes various levels of IFITM protein regulation and the physiological and pathological functions of these proteins, with an emphasis on tumorigenesis and antitumor immunity.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
10608 - Biochemistry and molecular biology
Result continuities
Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2022
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Frontiers in immunology
ISSN
1664-3224
e-ISSN
1664-3224
Volume of the periodical
13
Issue of the periodical within the volume
November 2022
Country of publishing house
CH - SWITZERLAND
Number of pages
25
Pages from-to
1042368
UT code for WoS article
000893123200001
EID of the result in the Scopus database
2-s2.0-85143308904